- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
166 Cards in this Set
- Front
- Back
|
Somatropin, Somatrem
|
Somatropin = recombinant GH
|
|
Sermorelin
|
GHRH analog
|
|
Mecasermin
|
Recombinant human IGF-1/IGF-3 complex
|
|
Pegvisomant
|
GH receptor antagonist
|
|
Octreotide
|
Somatostatin Analog
|
|
Bromocriptine, Cabergoline
|
Dopamine Agonists
|
|
Menotropins
|
Human menopausal gonadotropins (hMG)
|
|
Follitropin and Urofollitropin
|
Purified FSH
|
|
hCG
|
Extracted and purified from urine (given IM)
|
|
Gonadorelin, Goserelin, Leuprolide, Nafarelin
|
GnRH analogs
|
|
Cetrorelix, Ganirelix
|
GnRH Receptor Antagonists
|
|
Corticotropin, Cosyntropin
|
Adrenocorticotropic Hormone Analog
|
|
Oxytocin
|
Pharmacokinetics: Half life of 5 minutes
|
|
Atosiban
|
Oxytocin Antagonist
|
|
Vasopressin, Desmopressin
|
Released in response to rising plasma tonicity or falling BP
|
|
Conivaptan
|
Vasopressin Antagonist
|
|
Hydrocortisone
|
Stimulates/is required for gluconeogenesis (mostly) and glycogen synthesis in fasting state
|
|
Prednisone, Methylprednisolone, Dexamethasone, Beclomethasone, Triamcinolone
|
Synthetic Glucocorticoids
|
|
Fludrocortisone
|
Synthetic Corticosteroid (similar to Aldosterone), most commonly prescribed salt-retaining hormone
|
|
Spironolactone
|
Mineralocorticoid Antagonist
|
|
Mifepristone
|
Progesterone Antagonist: Antagonist at glucocorticoid and progesterone receptors
|
|
Aminoglutethimide
|
Corticosteroid Synthesis Inhibitor
|
|
Ketoconazole
|
Corticosteroid Synthesis Inhibitor (anti-androgen)
|
|
Metyrapone
|
Corticosteroid Synthesis Inhibitor
|
|
Estradiol, Estrone, Conjugated estrogen (Premarin), Ethinyl Estradiol, Quinestrol, Mestranol
|
Pharmacokinetics: Oral, IM, transdermal, and topical
|
|
Tamoxifen, Raloxifene
|
Selective Estrogen Receptor Modulators (SERMs)
|
|
Fluvestrant
|
Selective Estrogen Receptor Downregulator (SERDs)
|
|
Letrozole, Anastrozole, Exemestane
|
Aromatase Inhibitors, inhibit the conversion of androgens to estrogen
|
|
Danazol
|
Inhibitor of P450 in gonadal steroid synthesis
|
|
Clomiphene
|
Estrogen antagonist in the hypothalamus and anterior pituitary
|
|
Medroxyprogesterone, Norgestrel, Norethindrone, Norgestimate
|
Uses: Contraception (+/- estradiol), HRT (with estrogen), promote and maintain pregnancy, used in ovarian suppression, diagnosing endogenous estrogen secretion
|
|
Testosterone, Oxandrolone, Stanozolol, Fluoxymesterone, Oxymetholone, Nandrolone, Methyltestosterone, Oxymetholone
|
Use: Substitution therapy in hypogonadism, increases bone density (osteoporosis), can increase muscle mass, use in aplastic anemia
|
|
Flutamide, Bicalutamide, Nilutamide
|
Androgen Receptor Antagonists
|
|
Finasteride, Dutasteride
|
5-α reductase inhibitors, inhibiting the conversion of testosterone to dihydrotestosterone
|
|
Cyproterone Acetate
|
Anti-androgen
|
|
Insulin Lispro, Insulin Aspart, Insulin Glulisine
|
Rapid-acting Insulins
|
|
Crystalline Zinc Insulin (Regular Insulin)
|
Short-acting Insulin
|
|
Neutral Protamine Hagedorn (NPH) Insulin
|
Intermediate-acting Insulin, also called Isophane Insulin
|
|
Insulin Glargine, Insulin Detemir
|
Long-acting Insulins
|
|
Drugs that can cause Hypoglycemia
|
Ethanol: inhibits gluconeogenesis
|
|
Drugs that can cause Hyperglycemia
|
Direct effects countering insulin: Epinephrine, glucocorticoids, atypical antipsychotics, HIV protease inhibitors
|
|
Tolbutamide
|
First-generation Sulfonylurea
|
|
Chlorpropamide
|
First-generation Sulfonylurea
|
|
Glyburide (Glibenclamide), Glipizide, Glimepiride
|
2nd Generation Sulfonureas
|
|
Repaglinide, Nateglinide
|
Meglitinides
|
|
Metformin
|
Biguanide, 1st line treatment for DM Type 2
|
|
Pioglitazone, Rosiglitazone
|
Thiazolidinediones (Glitazones)
|
|
Acarbose, Miglitol
|
α-Glucosidase Inhibitors (competitive inhibitors)
|
|
Exenatide
|
Glucagon-like Polypeptide 1 (GLP-1) Analog [Incretin Analog]
|
|
Sitagliptin
|
Inhibitor of DPP-IV
|
|
Pramlintide
|
Synthetic Amylin Analog
|
|
Colesevelam
|
Bile-acid Sequestrant
|
|
Glucagon
|
Uses: Severe Hypoglycemia, Radiology of the bowel (relaxes the intestine), β-blocker poisoning
|
|
Thyroxine T4 (Levothyroxine) and Triodothyronine T3 (Liothyronine)
|
Thyroid Hormones
|
|
Propythiouracil (PTU), Methimazole
|
Thioamides
|
|
Iodine and Iodide Salts
|
-Used as a short-term inhibition of thyroid hormone synthesis (Wolff-Chiakoff Effect)--> after 10-14 days iodide effect escapes
|
|
Radioactive Iodine
|
Taken up and sequestered by the thyroid gland--> damage through emission of toxic β-particle
|
|
Other Anti-thyroid Drugs
|
1)β-blockers--> Useful in controlling CVS effects, especially during the thyroid storm
|
|
Teriparatide
|
Recombinant PTH (DNA analog)
|
|
Vitamin D
|
Acts by activating steroidal nuclear receptor
|
|
Calcitonin
|
Peptide Hormone
|
|
Sevelamer
|
Phosphate binding drug used to prevent hyperphosphatemia in patients with chronic renal failure
|
|
Calcium Salts
|
Oral: Ca carbonate/citrate/lactate
|
|
Bisphosphonates: Etidronate, Alendronate, Pamidronate, Risedronate
|
MOA: Inhibit osteoclastic activity by disrupting the mevalonate pathway--> decreasing the osteoclast H+ ATPase
|
|
Cinacalcet
|
Activates the Ca2+ sensing receptors in parathyroid cells-- suppression of PTH synthesis and release
|
|
Other Drugs Affecting Calcium Homeostasis
|
1) Fluoride--> Chronic exposure can lead to new bone synthesis which is denser, but brittle
|
|
Echinacea (E purpurea)
|
Active elements: Flavonoids, polyacetylenes and caffeonyl conjugates
|
|
Ephedra (Ma Huang)
|
Combination of ephedrine + pseudoephedrine
|
|
Garlic (Allium satium)
|
Active component: Organic thiosulfinate, which is converted into allicin
|
|
Ginkgo
|
Active constituents: Flavone glycosides and terpenoids
|
|
Ginseng
|
Active component: Ginsenosides
|
|
Milk Thistle
|
Active component: Silymarin (flavonolignans)
|
|
St. John's Wort
|
Active ingredients: Hypericin and hyperforin
|
|
Saw Palmetto
|
Active components: photosterols, aliphatic alcohols, polyprenes, and flavanoids
|
|
Coenzyme Q10 (Ubiquinone)
|
Purified Nutritional Substance
|
|
Glucosamine
|
Purified Nutritional Substance
|
|
Melatonin
|
Effects: Improves sleep onset, duration and quality--> used in sleep disorders and in those with jet lag
|
|
Black Cohosh (Actaea racemosa)
|
May possess analgesic, sedative and anti-inflammatory properties
|
|
Kava
|
Active compound: kavalactone
|
|
3-Step Ladder
|
Step 1: Aspirin, Acetaminophen, NSAIDs
|
|
End of life question (will be on the test)
|
Morphine is the DOC for Breathlessness in end-of-life care
|
|
Aspirin Toxicity
|
Poisoning: uncoupling of oxidative phosphorylation and disruption of normal cellular metabolism--> Impaired ability to generate ATP
|
|
Acetominophen Toxicity
|
Severe Cases: Fulminant liver failure--> Hepatic encephalopathy--> death
|
|
Amphetamine/Stimulant Toxicity
|
At high doses: Agitation, acute psychosis, HTN, tachycardia, TACHYARRHYTMIAS
|
|
Anticholinergic Toxicity
|
Signs: Red as a beet (Skin flushed), Hot as a hare (hyperthermia), Dry as a bone (dry mucous membranes/lack of sweating), Blind as a bat (blurred vision, cycloplegia, pupillary dilation), Mad as a hatter (confusion, delirium) + Tachycardia
|
|
β-Blocker Toxicity
|
Propranolol is most toxic-->blocks Na+ channels at high doses and is lipophilic (CNS effects)
|
|
Calcium Channel Blocker Toxicity
|
Effects: Depress SA automaticity and slow AC node conduction, reduce CO and BP
|
|
TCA Toxicity
|
Normal Action: Antagonists at muscarinic receptors, are α-blockers (vasodilation/hypotension), and have quinidine-like depressant effects (blockade of fast Na+ channels) which slow conduction and depresses cardiac contractility
|
|
MAOI Toxicity
|
Signs: Severe HTN reactions with tyramine-containing foods/drugs (aged cheese, red wine, phenylpropanolamine, ephedrine)
|
|
Neuroleptic Malignant Syndrome
|
Hyperthermic Disorder seen in patients who use Anti-psychotic agents (dopamine agonists)
|
|
Opioid Toxicity
|
Mild/moderate overdose: Lethargy, SMALL PUPILs, BP/pulse rate decreased
|
|
Sulfonylurea and Meglitinide Toxicity
|
Treatment: Glucose bolus + IV OCTREOTIDE
|
|
CO Toxicity
|
Colorless, tasteless, odorless, and nonirritating gas
|
|
Ethanol Toxicity
|
Treatment: IV DEXTROSE (glucose), THIAMINE (for Wernicke-Korsakoff syndrome), and correct electrolyte balance
|
|
Methanol Toxicity
|
Metabolized into formaldehyde and FORMIC ACID (toxic)
|
|
Ethylene Glycol Toxicity
|
Used in heat exchangers, coolents, antifreeze formulations, industrial solvents and hydraulic brake fluids
|
|
Organophosphate/Carbamate Toxicity
|
Normal Action: Cholinesterase Inhibitors
|
|
Warfarin Toxicity
|
Rodenticide
|
|
Cyanide Toxicity
|
Common in plastic/jewelry manufacturing, burning of wool/silk, consumption of cassava root or apricot seed
|
|
Lead Toxicity
|
From industrial exposure, lead-containing paint chips (children)
|
|
Arsenic Toxicity
|
Toxicity (increasing order): Organic arsenicals < pentavalent aresenic < trivalent arsenic < arsine
|
|
Mercury Toxicity
|
Found in the industries such as battery, thermometer, and barometer
|
|
Iron Toxicity
|
Acute iron toxicity: Vomiting, GI bleeding, lethargy, and GRAY CYANOSIS
|
|
Tranylcypromine, Phenelzine, Isocarboxazid, Selegiline
|
MAOIs: Increase levels of NE, serotonin, and dopamine
|
|
Amitriptyline, Clomipramine, Desipramine, Imipramine, Nortriptyline
|
TCAs: Block SERT and NET in addition to α-adrenergic, muscarinic, histamine, and 5-HT receptors
|
|
Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Citalopram, Escitalopram
|
SSRIs: specifically inhibit serotonin uptake
|
|
Venlafaxine, Duloxetine
|
SNRIs
|
|
Bupropion
|
Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs): inhibits uptake and increases release
|
|
Nefazodone, Trazodone
|
5HT2 Antagonist and (general) Reuptake Inhibitors (SARIs)
|
|
Mirtazapine
|
Noradrenergic and Specific Serotonergic Anti-depressants (NASSA)
|
|
Lithium
|
Use: Prophylactically for manic-depressive episodes and in treatment of manic episodes
|
|
Alternatives to Lithium
|
Valproate/Carbamazepine are commonly used
|
|
Chlorpromazine, Fluphenazine, Haloperidol, Thioridazine, Thiothixene
|
Classical Antipsychotics
|
|
Olanzapine, Clozapine, Quetiapine, Risperidone, Aripiprazole, Ziprasidone,
|
Atypical Antipsychotics
|
|
Benzodiazepines
|
Sedatives--> NON-LINEAR dose-response curve
|
|
Barbituates
|
Sedatives--> LINEAR dose-response curve
|
|
Zolpidem, Zaleplon, Eszopiclone
|
Non-benzodiazepine Benzodiazepine Receptor Agonists
|
|
Buspirone
|
5-HT1A PARTIAL Agonist, Anxiolytic
|
|
Ramelteon
|
Agonist at MT1/MT2 Melatonin Receptors
|
|
Chloral Hydrate, Meprobamate, Paraldehyde
|
Older Sedative-Hypnotics
|
|
Other Sedative (related) Drugs
|
Hydroxyzine: Antihistamine with antiemetic activity
|
|
Benztropine and Trihexyphenidyl
|
Anti-muscarinics used to treat parkinsonism
|
|
Levodopa + Carbidopa = Sinemet
|
Precursor of dopamine
|
|
Pramipexole, Ropinirole
|
Nonergot Dopamine Agonists
|
|
Rotigotine
|
Nonergot Dopamine Agonist
|
|
Apomorphine
|
Nonergot Dopamine Agonist
|
|
Selegiline (Deprenyl)
|
Selective and irreversible inhibitor of MAO-B (which selectively metabolizes dopamine)
|
|
Rasagiline
|
Selective and irreversible inhibitor of MAO-B (which selectively metabolizes dopamine)
|
|
Tolcapone, Entacapone
|
Catechol-O-Methyltransferase Inhibitors (COMT)
|
|
Amantadine
|
Antiviral drug used for Parkinson's Disease
|
|
Anti-epileptic Drugs
|
DOC for Simple/Complex Partial and Secondarily Generalized tonic-clonic seizures: Carbamazepine, Oxacarbazepine, Lamotrigine, Phenytoin
|
|
Phenytoin
|
Anti-epileptic
|
|
Carbamazepine
|
Anti-epileptic
|
|
Lamotrigine, Zonisamide
|
Anti-epileptic
|
|
Valproate
|
Anti-epileptic
|
|
Topiramate
|
Anti-epileptic
|
|
Ethosuximide
|
Anti-epileptic
|
|
Tiagabine
|
Anti-epileptic
|
|
Vigabatrin
|
Anti-epileptic
|
|
Gabapentin, Pregabalin
|
Anti-epileptics
|
|
Caffeine, Theophylline, Theobromine
|
Methylxanthines
|
|
Cocaine
|
MOA: Inhibits DOPAMINE, NE, and serotonin uptake
|
|
Amphetamine, Methamphetamine, Phenmetrazine, Methylphenidate
|
MOA: Increase release of catecholamines, weak inhibitors of MAO, possible direct catecholaminergic agonists on the brain
|
|
Nicotine
|
Actions: ganglionic stimulation by depolarization (low doses) and ganglionic blockade at high doses
|
|
Heroin, Morphine, Codeine, Oxycodone, Meperidine, Fentanyl, Alfentanil, Remifentanil
|
Opioids
|
|
Marijuana
|
9-Tetrahydrocannabinol produces most of the effects
|
|
LSD, Mescaline, Psilocybin
|
MOA: Agonist effects at the 5-HT2 receptors in the CNS
|
|
Phencyclidine (PCP)
|
1st used as an anesthetic
|
|
MDMA
|
Actions: Fosters feelings of empathy and intimacy without impairing intellectual capacities
|
|
Volatile Organic Solvents
|
Inhalants including gasoline, paint thinner, lighter fluid, glue and degreasers
|
|
Nitrous Oxide
|
Inhaled Anesthetic, Gas
|
|
Halothane, Enflurane, Isoflurane, Desflurane, Sevoflurane, Methoxyflurane
|
Inhaled Anesthetics, Volatile Halogenated Hydrocarbons
|
|
Malignant Hyperthermia
|
AD phenomenon triggered by exposure to volatile inhalation anaesthetics and depolarizing skeletal muscle relaxants (succinylcholine)
|
|
Benzodiazepines as IV Anesthetics
|
Diazepam, Lorazepam, and MIdazolam
|
|
Propofol
|
Common IV Anesthetic used for induction/maintenance of anesthesia
|
|
Etomidate
|
IV Anesthetic
|
|
Ketamine
|
IV Anesthetic
|
|
Anti-muscarinic Anesthetic Adjuvants
|
Reasons: Amnesic effects, prevention of salivation and bronchial secretions, protection of heart form bradycardia caused by inhalational agents and neuromuscular blockers
|
|
Procaine, Cocaine, Tetracaine, Benzocaine
|
Ester Local Anesthetics
|
|
Lidocaine, Bupicaine, Prilocaine, Ropivacaine
|
Amide Local Anesthetics
|
|
Tubocurarine, Atracurium, Cisatracurium, Doxacurium, Mivacurium
|
Non-Depolarizing Neuromuscular blockers Benzylisoquinolines
|
|
Pancuronium, Pipecuronium, Rocuronium, Vecuronium
|
Non-Depolarizing Neuromuscular blockers Ammonio Steroids (contain esters hydrolyzed in the liver)
|
|
Succinylcholine
|
Depolarizing Neuromuscular Blocker
|
|
Chronic Spasmolytics acting in the CNS
|
Diazepam: Facilitates action of GABA at GABAa receptors
|
|
Chronic Spasmolytics acting on the Skeletal Muscle
|
Dantrolene and Botulism
|
|
Cyclobenzaprine
|
Used for relief of ACUTE muscle spasm
|